Published in Lab Invest on September 15, 2008
Medulloblastoma exosome proteomics yield functional roles for extracellular vesicles. PLoS One (2012) 1.08
Three-dimensional culture systems in cancer research: Focus on tumor spheroid model. Pharmacol Ther (2016) 1.06
Dynamic magnetic resonance imaging assessment of vascular targeting agent effects in rat intracerebral tumor models. Neuro Oncol (2010) 1.02
LKB1 represses focal adhesion kinase (FAK) signaling via a FAK-LKB1 complex to regulate FAK site maturation and directional persistence. J Biol Chem (2013) 0.92
A case of early extraneural medulloblastoma metastases in a young adult. Asian J Neurosurg (2015) 0.92
Activation of circulated immune cells and inflammatory immune adherence are involved in the whole process of acute venous thrombosis. Int J Clin Exp Med (2014) 0.91
Increased expressions of integrin subunit β1, β2 and β3 in patients with venous thromboembolism: new markers for venous thromboembolism. Int J Clin Exp Med (2014) 0.86
ID3 contributes to cerebrospinal fluid seeding and poor prognosis in medulloblastoma. BMC Cancer (2013) 0.85
Interaction between the extracellular matrix and lymphatics: consequences for lymphangiogenesis and lymphatic function. Matrix Biol (2010) 0.84
Applications of snake venom components to modulate integrin activities in cell-matrix interactions. Int J Biochem Cell Biol (2013) 0.84
Serum free cultured bone marrow mesenchymal stem cells as a platform to characterize the effects of specific molecules. PLoS One (2010) 0.84
Integrin alpha9 (ITGA9) expression and epigenetic silencing in human breast tumors. Cell Adh Migr (2011) 0.83
Radiation-induced motility alterations in medulloblastoma cells. J Radiat Res (2015) 0.82
Notch-mediated induction of N-cadherin and α9-integrin confers higher invasive phenotype on rhabdomyosarcoma cells. Br J Cancer (2012) 0.79
The effect of alpha-v integrin inhibition on the malignant characteristics of medulloblastoma. J Neurosurg Pediatr (2012) 0.76
Combined EphB2 receptor knockdown with radiation decreases cell viability and invasion in medulloblastoma. Cancer Cell Int (2017) 0.75
Internal relationship between symptomatic venous thromboembolism and risk factors: up-regulation of integrin β1, β2 and β3 levels. Am J Transl Res (2015) 0.75
Discriminating the Independent Influence of Cell Adhesion and Spreading Area on Stem Cell Fate Determination Using Micropatterned Surfaces. Sci Rep (2016) 0.75
Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature (2002) 15.36
Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease. Nat Genet (2001) 4.48
Integrin-linked kinase: a cancer therapeutic target unique among its ILK. Nat Rev Cancer (2005) 3.83
Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study. J Clin Oncol (1999) 3.08
Synaptic adhesion molecules. Curr Opin Cell Biol (2003) 2.74
Recent advances in the treatment of malignant astrocytoma. J Clin Oncol (2006) 2.55
Integrating the MAP kinase signal into the G1 phase cell cycle machinery. Bioessays (2000) 2.22
Signalling via integrins: implications for cell survival and anticancer strategies. Biochim Biophys Acta (2006) 2.18
Differential expression of thrombospondin 1, 2, and 3 during murine development. Dev Dyn (1993) 1.92
Sequence and tissue distribution of the integrin alpha 9 subunit, a novel partner of beta 1 that is widely distributed in epithelia and muscle. J Cell Biol (1993) 1.82
Beta 1-integrins regulate the formation and adhesion of ovarian carcinoma multicellular spheroids. Am J Pathol (2001) 1.69
CD44 and beta1 integrin mediate ovarian carcinoma cell adhesion to peritoneal mesothelial cells. Am J Pathol (1999) 1.60
New insights into the diversity and function of neuronal immunoglobulin superfamily molecules. Annu Rev Neurosci (2003) 1.58
Integrin-mediated adhesion regulates ERK nuclear translocation and phosphorylation of Elk-1. J Cell Biol (2001) 1.54
MYC messenger RNA expression predicts survival outcome in childhood primitive neuroectodermal tumor/medulloblastoma. Clin Cancer Res (2001) 1.46
beta1-integrin-mediated signaling essentially contributes to cell survival after radiation-induced genotoxic injury. Oncogene (2006) 1.41
ERBB2 up-regulates S100A4 and several other prometastatic genes in medulloblastoma. Cancer Res (2003) 1.41
The extracellular matrix of the central and peripheral nervous systems: structure and function. J Neurosurg (1988) 1.32
Increased caveolin-1 expression precedes decreased expression of occludin and claudin-5 during blood-brain barrier breakdown. Acta Neuropathol (2007) 1.31
Advances in the diagnosis, molecular genetics, and treatment of pediatric embryonal CNS tumors. Oncologist (2003) 1.24
Differential spectrum of expression of neural cell adhesion molecule isoforms and L1 adhesion molecules on human neuroectodermal tumors. Cancer Res (1990) 1.23
Distribution of type VI collagen in human gliomas: comparison with fibronectin and glioma-mesenchymal matrix glycoprotein. J Neuropathol Exp Neurol (1987) 1.20
Pepsin pretreatment allows collagen IV immunostaining of blood vessels in adult mouse brain. J Neurosci Methods (2007) 1.12
Construction of an artificial blood vessel wall from cultured endothelial and smooth muscle cells. Proc Natl Acad Sci U S A (1979) 1.09
Fibronectin in multiple sclerosis lesions. Am J Pathol (1989) 1.08
Inhibition of growth and induction of differentiation in a malignant human glioma cell line by normal leptomeningeal extracellular matrix proteins. Cancer Res (1987) 1.04
An ultrastructural and immunocytochemical analysis of leptomeningeal and meningioma cultures. J Neuropathol Exp Neurol (1986) 1.02
Tenascin-R and C in multiple sclerosis lesions: relevance to extracellular matrix remodelling. Neuropathol Appl Neurobiol (1999) 1.01
Inhibitory effects of MLDG-containing heterodimeric disintegrins reveal distinct structural requirements for interaction of the integrin alpha 9beta 1 with VCAM-1, tenascin-C, and osteopontin. J Biol Chem (2000) 1.00
Fibronectin-like immunoreactivity in the developing cerebral cortex. J Neurosci (1987) 1.00
Specific pattern of growth factor distribution in chronic subdural hematoma (CSH): evidence for an angiogenic disease. Acta Neurochir (Wien) (2001) 0.98
Structural requirements of MLD-containing disintegrins for functional interaction with alpha 4 beta 1 and alpha 9 beta1 integrins. Biochemistry (2004) 0.95
Distribution of vitronectin mRNA during murine development. Dev Dyn (1995) 0.95
Neuroectodermal tumors of the peripheral and the central nervous system share neuroendocrine N-CAM-related antigens with small cell lung carcinomas. Acta Neuropathol (1991) 0.94
Differential motile response of human malignant mesothelioma cells to fibronectin, laminin and collagen type IV: the role of beta1 integrins. Int J Cancer (1997) 0.93
Differential role of beta(1C) and beta(1A) integrin cytoplasmic variants in modulating focal adhesion kinase, protein kinase B/AKT, and Ras/Mitogen-activated protein kinase pathways. Mol Biol Cell (2000) 0.92
Immunological characterization of eristostatin and echistatin binding sites on alpha IIb beta 3 and alpha V beta 3 integrins. Biochem J (1996) 0.92
The extracellular matrix composition of the monkey optic nerve head. Invest Ophthalmol Vis Sci (1988) 0.90
Expression of basement membrane and endothelial cell adhesion molecules in vascular malformations of the brain: preliminary observations and working hypothesis. Neurol Res (1995) 0.90
Brain angiogenesis: variations in vascular basement membrane glycoprotein immunoreactivity. Exp Neurol (1991) 0.87
Characterization of normal human brain cultures. Evidence for the outgrowth of leptomeningeal cells. Lab Invest (1986) 0.86
Distribution of extracellular matrix proteins in primary human brain tumours: an immunohistochemical analysis. Can J Neurol Sci (1987) 0.86
Concentrations of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3), IGF, and IGFBP-3 protease activity in cerebrospinal fluid of children with leukemia, central nervous system tumor, or meningitis. J Clin Endocrinol Metab (1993) 0.83
Immunocytochemical characterization of reactive optic nerve astrocytes and meningeal cells. Glia (1999) 0.83
Connection between integrins and cell activation in rat adrenal glomerulosa cells: a role for Arg-Gly-Asp peptide in the activation of the p42/p44(mapk) pathway and intracellular calcium. Endocrinology (2003) 0.83
E, N-cadherins and beta-catenin expression in medulloblastoma and atypical teratoid/rhabdoid tumor. Neurol Med Chir (Tokyo) (2004) 0.82
Vascular cell adhesion molecule-1 is a key adhesion molecule in melanoma cell adhesion to the leptomeninges. Lab Invest (2002) 0.82
Medulloblastoma cell-substrate interaction in vitro. Invasion Metastasis (1991) 0.82
Disialoganglioside GD2 in human neuroectodermal tumor cell lines and gliomas. Acta Neuropathol (1991) 0.81
Growth of a medulloblastoma on normal leptomeningeal cells in culture: interaction of tumor cells and normal cells. Neurosurgery (1987) 0.81
Developmental regulation of decorin expression in postnatal rat brain. Brain Res (1998) 0.80
Pleural mesothelioma mimics the integrin profile of activated, sessile rather than detached mesothelial cells. Int J Cancer (1997) 0.80
Expression of the cluster 1 antigen (neural cell adhesion molecule) in neuroectodermal tumours. Br J Cancer Suppl (1991) 0.78
Immunohistochemical analysis for histopathological subtypes in pediatric medulloblastomas. Pathol Int (2003) 0.78
Regional diminution of von Willebrand factor expression on the endothelial covering arachnoid granulations of human, monkey and dog brain. Kurume Med J (2002) 0.78
Isolation, characterization, and substrate properties of the external limiting membrane from the avian embryonic optic tectum. J Neurosci Res (1990) 0.77
Primitive neuroectodermal tumors: ultrastructural and immunohistochemical studies. Ultrastruct Pathol (1995) 0.77
Tenascin in the injured rat optic nerve and in non-neuronal cells in vitro: potential role in neural repair. J Comp Neurol (1994) 0.77
Cellular and molecular mechanisms of metastasis as applied to carcinomatous meningitis. J Neurooncol (1998) 0.77
Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin Microbiol Rev (2012) 2.92
Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis. Lancet Oncol (2013) 2.82
Infectious agents and cancer: criteria for a causal relation. Semin Cancer Biol (2004) 2.20
Sonic hedgehog and insulin-like growth factor signaling synergize to induce medulloblastoma formation from nestin-expressing neural progenitors in mice. Oncogene (2004) 1.96
Detection of JC virus DNA fragments but not proteins in normal brain tissue. Ann Neurol (2008) 1.82
HIV-1 associated dementia: symptoms and causes. Retrovirology (2006) 1.70
Expression of human neurotropic polyomavirus JCV late gene product agnoprotein in human medulloblastoma. J Natl Cancer Inst (2002) 1.69
Early onset of neoplasia in the prostate and skin of mice with tissue-specific deletion of Pten. Proc Natl Acad Sci U S A (2004) 1.67
Cerebral hypoperfusion generates cortical watershed microinfarcts in Alzheimer disease. Stroke (2002) 1.66
Role of Pur alpha in targeting mRNA to sites of translation in hippocampal neuronal dendrites. J Neurosci Res (2006) 1.63
Regulation of gene expression in primate polyomaviruses. J Virol (2009) 1.61
Astrocyte-elevated gene-1 (AEG-1) induction by hypoxia and glucose deprivation in glioblastoma. Cancer Biol Ther (2011) 1.61
Interplay of cellular and humoral immune responses against BK virus in kidney transplant recipients with polyomavirus nephropathy. J Virol (2006) 1.58
Association of human polyomavirus JCV with colon cancer: evidence for interaction of viral T-antigen and beta-catenin. Cancer Res (2002) 1.54
Peroxisome proliferator-activated receptor alpha activation decreases metastatic potential of melanoma cells in vitro via down-regulation of Akt. Clin Cancer Res (2006) 1.49
Melanin synthesis in microorganisms--biotechnological and medical aspects. Acta Biochim Pol (2006) 1.47
Protective role of Puralpha to cisplatin. Cancer Biol Ther (2008) 1.44
Snake venom disintegrins: evolution of structure and function. Toxicon (2005) 1.43
Pathogenesis of progressive multifocal leukoencephalopathy--revisited. J Infect Dis (2011) 1.43
Development of a bidirectional caspase-3 expression system for the induction of apoptosis. Cancer Biol Ther (2008) 1.42
Role of Purα in the cellular response to ultraviolet-C radiation. Cell Cycle (2010) 1.41
Integrating role of T antigen, Rb2/p130, CTCF and BORIS in mediating non-canonical endoplasmic reticulum-dependent death pathways triggered by chronic ER stress in mouse medulloblastoma. Cell Cycle (2012) 1.41
Multiple roles for Puralpha in cellular and viral regulation. Cell Cycle (2009) 1.39
IKK{gamma} protein is a target of BAG3 regulatory activity in human tumor growth. Proc Natl Acad Sci U S A (2010) 1.36
JC virus-induced changes in cellular gene expression in primary human astrocytes. J Virol (2003) 1.36
TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma. Acta Neuropathol (2013) 1.35
Medulloblastoma: from molecular pathology to therapy. Clin Cancer Res (2008) 1.30
Salmonella enterica serovar enteritidis core O polysaccharide conjugated to H:g,m flagellin as a candidate vaccine for protection against invasive infection with S. enteritidis. Infect Immun (2011) 1.29
Macrophage/microglial accumulation and proliferating cell nuclear antigen expression in the central nervous system in human immunodeficiency virus encephalopathy. Am J Pathol (2004) 1.28
Interaction of alpha9beta1 integrin with thrombospondin-1 promotes angiogenesis. Circ Res (2007) 1.28
Cross talk between the cardiovascular and nervous systems: neurotrophic effects of vascular endothelial growth factor (VEGF) and angiogenic effects of nerve growth factor (NGF)-implications in drug development. Curr Pharm Des (2006) 1.27
BAG3 protein is overexpressed in human glioblastoma and is a potential target for therapy. Am J Pathol (2011) 1.27
Inhibition of p66ShcA longevity gene rescues podocytes from HIV-1-induced oxidative stress and apoptosis. J Biol Chem (2009) 1.24
CCL8/MCP-2 is a target for mir-146a in HIV-1-infected human microglial cells. FASEB J (2010) 1.23
Fenofibrate-induced nuclear translocation of FoxO3A triggers Bim-mediated apoptosis in glioblastoma cells in vitro. Cell Cycle (2012) 1.23
Activation of the oxidative stress pathway by HIV-1 Vpr leads to induction of hypoxia-inducible factor 1alpha expression. J Biol Chem (2009) 1.21
Evidence for involvement of Wnt signaling pathway in IB-MECA mediated suppression of melanoma cells. Oncogene (2002) 1.21
Activated IGF-1R inhibits hyperglycemia-induced DNA damage and promotes DNA repair by homologous recombination. Am J Physiol Renal Physiol (2005) 1.21
Persistence and pathogenesis of the neurotropic polyomavirus JC. Ann Neurol (2015) 1.21
Role of the insulin-like growth factor I/insulin receptor substrate 1 axis in Rad51 trafficking and DNA repair by homologous recombination. Mol Cell Biol (2003) 1.21
Polyomaviruses and human cancer: molecular mechanisms underlying patterns of tumorigenesis. Virology (2004) 1.21
Evidence for BAG3 modulation of HIV-1 gene transcription. J Cell Physiol (2007) 1.20
Identification of novel beta1 integrin binding sites in the type 1 and type 2 repeats of thrombospondin-1. J Biol Chem (2004) 1.19
Inhibition of SNAP25 expression by HIV-1 Tat involves the activity of mir-128a. J Cell Physiol (2008) 1.19
Evidence for dysregulation of cell cycle by human polyomavirus, JCV, late auxiliary protein. Oncogene (2002) 1.19
Functional interaction between JC virus late regulatory agnoprotein and cellular Y-box binding transcription factor, YB-1. J Virol (2002) 1.17
Insulin-like growth factor I receptor activity in human medulloblastomas. Clin Cancer Res (2002) 1.15
Detection of JC virus DNA sequences and expression of viral T antigen and agnoprotein in esophageal carcinoma. Cancer (2005) 1.15
ROS accumulation and IGF-IR inhibition contribute to fenofibrate/PPARalpha -mediated inhibition of glioma cell motility in vitro. Mol Cancer (2010) 1.15
Role of JC virus agnoprotein in DNA repair. J Virol (2004) 1.14
Progressive multifocal leukoencephalopathy: clinical and molecular aspects. Rev Med Virol (2011) 1.13
Primary central nervous system lymphoma expressing the human neurotropic polyomavirus, JC virus, genome. J Virol (2004) 1.13
Morphine treatment of human monocyte-derived macrophages induces differential miRNA and protein expression: impact on inflammation and oxidative stress in the central nervous system. J Cell Biochem (2010) 1.13
Tubulin-mediated binding of human immunodeficiency virus-1 Tat to the cytoskeleton causes proteasomal-dependent degradation of microtubule-associated protein 2 and neuronal damage. J Neurosci (2006) 1.12
Phosphorylation mutants of JC virus agnoprotein are unable to sustain the viral infection cycle. J Virol (2006) 1.12
Molecular mechanisms of necrosis in glioblastoma: the role of glutamate excitotoxicity. Cancer Biol Ther (2009) 1.10
Role for tumor necrosis factor-α in JC virus reactivation and progressive multifocal leukoencephalopathy. J Neuroimmunol (2010) 1.10
Snake venom disintegrins: novel dimeric disintegrins and structural diversification by disulphide bond engineering. Biochem J (2003) 1.10
Alterations of DNA damage repair pathways resulting from JCV infection. Virology (2007) 1.10
The rapidly expanding family of human polyomaviruses: recent developments in understanding their life cycle and role in human pathology. PLoS Pathog (2013) 1.10
Class III beta-tubulin is constitutively coexpressed with glial fibrillary acidic protein and nestin in midgestational human fetal astrocytes: implications for phenotypic identity. J Neuropathol Exp Neurol (2008) 1.09
Human polyomavirus JCV late leader peptide region contains important regulatory elements. Virology (2006) 1.09
T-antigen of the human polyomavirus JC attenuates faithful DNA repair by forcing nuclear interaction between IRS-1 and Rad51. J Cell Physiol (2006) 1.08
Expression of JC virus regulatory proteins in human cancer: potential mechanisms for tumourigenesis. Eur J Cancer (2005) 1.08
Activation of PPARalpha inhibits IGF-I-mediated growth and survival responses in medulloblastoma cell lines. Int J Cancer (2008) 1.08
Effect of HIV-1 Vpr on cell cycle regulators. DNA Cell Biol (2004) 1.08
Beta-amyloid deposition and Alzheimer's type changes induced by Borrelia spirochetes. Neurobiol Aging (2006) 1.08
Cooperative interaction of C/EBP beta and Tat modulates MCP-1 gene transcription in astrocytes. J Neuroimmunol (2005) 1.07
Interplay between HIV-1 Vpr and Sp1 modulates p21(WAF1) gene expression in human astrocytes. J Biol Chem (2004) 1.07
Intracellular approach for blocking JC virus gene expression by using RNA interference during viral infection. J Virol (2004) 1.06
JC virus agnoprotein inhibits in vitro differentiation of oligodendrocytes and promotes apoptosis. J Virol (2007) 1.05
Interferon regulatory factor 7 is associated with Epstein-Barr virus-transformed central nervous system lymphoma and has oncogenic properties. J Virol (2004) 1.05
Early growth response-1 protein is induced by JC virus infection and binds and regulates the JC virus promoter. Virology (2008) 1.05
Modulation of JC virus transcription by C/EBPbeta. Virus Res (2009) 1.05
Augmentation of integrin-mediated mechanotransduction by hyaluronic acid. Biomaterials (2013) 1.05
Human polyomaviruses and brain tumors. Brain Res Brain Res Rev (2005) 1.04
Subpopulations of myeloid-derived suppressor cells impair T cell responses through independent nitric oxide-related pathways. Int J Cancer (2013) 1.04
Mutations in genes encoding the glycine cleavage system predispose to neural tube defects in mice and humans. Hum Mol Genet (2011) 1.03
Outcome of simian-human immunodeficiency virus strain 89.6p challenge following vaccination of rhesus macaques with human immunodeficiency virus Tat protein. J Virol (2002) 1.03
Beta amyloid and hyperphosphorylated tau deposits in the pancreas in type 2 diabetes. Neurobiol Aging (2008) 1.03
Interaction between JCV large T-antigen and beta-catenin. Oncogene (2004) 1.03
Regulation of MCP-1 gene transcription by Smads and HIV-1 Tat in human glial cells. Virology (2003) 1.03
Dephosphorylation of JC virus agnoprotein by protein phosphatase 2A: inhibition by small t antigen. Virology (2008) 1.02
Effects of JC virus infection on anti-apoptotic protein survivin in progressive multifocal leukoencephalopathy. Am J Pathol (2007) 1.02
Cdk9 phosphorylates p53 on serine 392 independently of CKII. J Cell Physiol (2006) 1.02
Regulatory effect of nerve growth factor in alpha9beta1 integrin-dependent progression of glioblastoma. Neuro Oncol (2008) 1.02
Integrin alpha9 beta1 is a receptor for nerve growth factor and other neurotrophins. J Cell Sci (2008) 1.02